GSK

Sotrovimab Injection

Manufacturer:

GSK

Sotrovimab Injection HCPCS:

Q0247

HCPCS Code Descriptor:

Injection, sotrovimab, 500 mg

Category:

Q Code

Sotrovimab Injection NDCs:

No actively aligned NDCs found

Primary Type:

COVID-19

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Sotrovimab Injection CPT Codes:

Potential CPT administration codes for Sotrovimab Injection can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Sotrovimab Injection:

Sotrovimab Injection is a COVID-19 drug manufactured by GSK and administered via the Intravenous route of administration. The Q Code: Q0247 is aligned to the drug Sotrovimab Injection.

ACCESS PRICING AND MORE BY REGISTERING

Q0247 Added Date:

May 26, 2021

Q0247 Effective Date:

May 26, 2021

Q0247 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Sotrovimab Injection billing and coding information.
Our team did not identify a source for Sotrovimab Injection patient assistance information. Please reach out to our team if you feel that this is a mistake.
Sotrovimab Injection prescribing information can be found at the link below:
Information regarding Sotrovimab Injection’s side effects can be found at MedlinePlus